CDC Analysis Details 112 Measles Cases in Pregnant Women

Scientists at the Centers for Disease Control and Prevention have published a national analysis detailing 112 cases of measles in pregnant women, a development that follows months of internal debate over how to warn the medical community.

The data, released Monday in NEJM Evidence, provides the first national look at measles complications during pregnancy since the country began seeing a surge in cases.

The United States is expected to lose its status as a country that has eliminated measles, a designation it held for more than 25 years. The Pan American Health Organization plans to make this announcement public on Tuesday, according to The Washington Post.

Complications in pregnancy and newborns

The analysis covers a 21-month period ending Sept. 28, during which 112 pregnant women contracted the virus. Of those cases, 26 women required hospitalization for reasons other than labor, including 11 who developed pneumonia and two who experienced respiratory failure, The Washington Post reported.

"This is much worse than we thought," Michael Osterholm, a public health expert at the University of Minnesota, noted in comments relayed by The New York Times.

Health usa measles poll
Photo: The Independent

The report identified 13 newborns with congenital measles, defined as infants born to mothers with confirmed cases who tested positive or developed symptoms within 10 days of birth. Eight of the 19 live births documented in the study were premature, and eight infants required admission to neonatal intensive care. The study also recorded two miscarriages and one stillbirth, though the authors noted it is unclear if measles directly caused these losses.

Delayed national health alert

CDC scientists had attempted to issue a formal warning to clinicians about the rising threat to pregnant women in September through the agency’s Health Alert Network, The Washington Post reported. The alert, which requires approval from the director’s office, was not cleared. Two people familiar with the internal deliberations, who spoke on the condition of anonymity, said they did not know why the request was denied.

A spokesperson for the Department of Health and Human Services said that CDC researchers chose an external journal for the study to reach clinicians as quickly as possible. The federal health department continues to face criticism over its handling of measles as the agency has not addressed why a specific Health Alert Network notification regarding measles risks during pregnancy remained unapproved.

Clinical guidance for exposure

The study includes specific recommendations for protecting susceptible pregnant women. Because the standard measles, mumps and rubella (MMR) vaccine cannot be administered during pregnancy, clinicians are advised to provide immune globulin within six days of exposure.

According to Margot Savoy, a family physician and chief medical officer with the American Academy of Family Physicians, in an email to The Washington Post, "We would have treated every pregnant patient’s measles immunity as an urgent question, not a routine one." She said that while journal articles serve as a record, health alerts are designed to provide immediate, actionable guidance for patients in the exam room.

Risks of measles during pregnancy and congenital measles

Why is measles dangerous during pregnancy?
Pregnant women have temporarily weakened immune systems, making them more susceptible to severe complications like pneumonia and respiratory failure. According to The New York Times, pregnant women are 10 times as likely to die from measles compared to the general population.

What is congenital measles?
Congenital measles occurs when an infected mother transmits the virus to her fetus. As noted by The Independent, this can lead to severe health complications for the newborn, including life-threatening inflammation of the brain and surrounding membranes.

How can doctors protect exposed patients?
For pregnant women who are unvaccinated or lack evidence of immunity, doctors can administer immune globulin within six days of exposure to provide antibodies against the virus. The study published in NEJM Evidence recommends this treatment for both the mother and for newborns exposed in the womb.